InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Griffin Michelle Renee. Director active across 2 companies, notably Adaptive Biotechnologies Corp. In total, 18 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €442k. Activity tracked since 18 May 2021. The latest transaction was filed on 11 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Griffin Michelle Renee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
52,084 sharesCommon StockSEC:0001229765-26-000008:0
52,084 sharesCommon StockSEC:0001229765-26-000008:1
15,394 shares@ US$13.9123.6% of flowCommon StockSEC:0001229765-26-000006:0
15,625 shares0Common StockSEC:0001229765-26-000004:0
48,044 shares@ US$3.9921.0% of flowCommon StockSEC:0001229765-26-000001:0
36,291 shares@ US$7.1939.6% of flowCommon StockSEC:0001062993-25-005644:0
15,394 shares0Common StockSEC:0001062993-25-004800:0
31,328 shares0Common StockSEC:0001062993-24-005770:0
3,300 sharesCommon StockSEC:0001209191-23-045422:0
3,300 sharesCommon StockSEC:0001209191-23-033188:0
2,341 shares@ US$8.49133.0% of flowCommon StockSEC:0001062993-23-008033:0
14,775 shares0Common StockSEC:0001062993-23-006333:0
6,689 shares0Common StockSEC:0001209191-22-005497:0
14,916 shares@ US$7.8012.7% of flowCommon StockSEC:0001209191-21-053971:0
2,500 shares@ US$7.802.1% of flowCommon StockSEC:0001209191-21-047303:0
4,000 shares@ US$7.803.4% of flowCommon StockSEC:0001209191-21-042289:0
2,500 shares@ US$7.802.1% of flowCommon StockSEC:0001209191-21-041089:0
2,500 shares@ US$7.802.0% of flowCommon StockSEC:0001209191-21-034235:0
18 of 18 declarations
About Griffin Michelle Renee
GRIFFIN MICHELLE RENEE is a declarant associated with Adaptive Biotechnologies Corp and Chinook Therapeutics, INC., where she is a Director. The 18 filings recorded run from 2021-05-19 to 2026-06-29, and within this sample of recent filings, sell transactions total EUR 442499 and the most frequent transaction nature is Exercise of options.
